French Maritime Pine Bark Supports Healthy Cardiac Function and Eye Health

french-maritime-pine-bark-supports-healthy-cardiac-function-and-eye-health.jpgYou may have heard that French Maritime pine bark extract, or Pinus pinaster, can reduce atherosclerosis. Hardening of the arteries is a leading cause of heart attacks and stroke. The middle-aged and seniors are vulnerable to high cholesterol, high blood pressure, and high blood sugar. Diet, exercise, and weight management are important for controlling metabolic syndrome. Additionally, this extract has been shown to alter fat metabolism and inflammation that are factors in atherosclerosis. How does French Maritime Pine bark extract address plaque build-up in the arteries?

Special Substances in French Maritime Pine Bark Extract

Procyanidins, phenolic acids, and other compounds are found in French Maritime Pine bark extract. These substances alter how the body metabolizes fat. They also reduce an important inflammation-signaling chemical. Chronic inflammation is widely accepted as a major player in hardening of the arteries. A scientific review1 summarized many benefits, including:
  • Supports immunity
  • Supports respiration
  • Fights oxidative stress
  • Contributes to lowering hypertension
  • Supports small blood vessel expansion
  • Reduces the effects of epinephrine and norepinephrine on blood vessel constriction
The last three points are related to coronary heart disease. Researchers have gone further to understand this supplement’s effect on plaque. The build-up of plaque is often symptomless until the person has a heart attack or stroke.

Research on Pine Bark and Plaque Build-Up

A small study2 looked at 23 patients who had coronary artery disease. They took 200 mg of French Maritime Pine Bark each day for two months. Researchers took measurements of the brachial artery in the forearm before, during, and after treatment. The subjects were also measured after they took a placebo (such as a sugar pill) for two months. During the placebo period, endothelial function did not change. However, after the pine bark treatment period, subjects had a 32% increase in endothelial function and in flow-mediate dilation. Oxidized fat levels were also lower after taking the extract. Another study looked at 93 seemingly-healthy subjects; however, they had risk factors for coronary disease.3 They were divided into equally-sized groups: subjects with elevated blood pressure, elevated blood sugar levels, and elevated blood lipids (cholesterol). In addition to continuing their medical symptom management, half took 150 mg of pine bark extract each day. Over the course of 12 weeks, the subjects who took the extract had an increase in flow-mediated dilation of 66%. The subjects who had no supplements stayed the same.

Conclusion

As most people age, they gradually develop metabolic syndrome. Without warning, they are at risk for stroke or heart attack. A healthy diet and daily exercise are important. Additionally, supplements such as French Maritime pine bark may reduce plaque build-up and keep the arteries flowing. Research into this supplement could lead to its wide acceptance for preventing heart disease. Editor’s Note: Eye Pressure Support formula contains Mirtogenol, a combination of French Martitime pine bark, bilberry and other extracts.

https://www.lvcenter4sight.com/french-maritime-pine-bark-supports-healthy-cardiac-function-and-eye-health/

Comments

Post a Comment

Popular posts from this blog

Week in review: Pay raise, Von’s Vision, gonio-<em>what?</em>

Image
APR 13, 2018 By Anni Griswold Comprehensive Ophthalmology, Cornea/External Disease, Glaucoma, Pediatric Ophth/Strabismus Above: The GonioPEN (Credit: Nanyang Technological University) A weekly roundup of ophthalmic news from around the web. Ophthalmologists earn more than the average physician , and their salaries are on the rise (+3% over the last year, to be precise). Eye docs will earn a mean $375,000 this year—more than the physician average of $299,000, but well below a typical plastic surgeon’s paycheck. See for yourself in Medscape’s 2018 Physician Compensation Report . Medscape A special supplement to USA Today will highlight the work of Von Miller , a 28-year-old linebacker for the Denver Broncos and former Super Bowl MVP. Through his foundation, Von’s Vision, Miller connects thousands of underprivileged children in Denver with affordable, high-quality eye care. His interview will appear in the “Vision Health” campaign during World Glaucoma Week, available in pr...
Read more

Patch with Microneedles Could Replace Eye Injections

Image
Instead of getting eye injections, patients with serious eye diseases may be eligible for a contact lens-type patch. 1 Injections are often recommended for eye diseases such as Wet (advanced) Age-Related Macular Degeneration, macular edema, and glaucoma. The new patch is inserted painlessly like a contact lens. It delivers tiny microneedles containing medication. The microneedles are made from natural materials and dissolve over time, gradually releasing medicine. Patients would be more likely to stick with a regimen that does not involve eye injections. Eye Injections: Stick a Needle in My Eye Patients generally dread eye injections. Injections must be performed in a doctor’s office. Eye injections can be painful, and they are inconvenient. They can introduce infection. And they can damage the eye. Avastin, Eylea, and Lucentis are injectable medications that discourage new blood vessel growth. These anti-VEGF medicines are useful for advanced Macular Degeneration , Diabetic Retino...
Read more

Incidence of eyelid SCC appears to be rising

FEB 12, 2018 Oculoplastics/Orbit This retrospective study examined demographic risk factors for developing eyelid squamous cell carcinoma (SCC). Study design Using data from the National Cancer Registration and Analysis Service, investigators identified all cases of eyelid SCC in England between 2000 and 2014. Outcomes Over the 15-year study period, there were 4,022 patients with newly diagnosed SCC affecting the eyelid. The age-standardized number of reported cases of eyelid SCC rose approximately 2% per year over the study period. The risk for developing an eyelid SCC approximately doubled each decade after age 60. Men were at 1.9-times greater relative risk compared with women. The authors did not find any association between income quintile and risk of SCC. Limitations The cause for the increasing incidence of eyelid SCC was not studied. While age may represent one factor, others such as an increasing rate of patients receiving immunosuppression therapies may als...
Read more